Pharmaceuticals

Breakout Signal: Broke out of a four-day consolidation phase, closing significantly above key resistance levels. Growth Drivers: Specializes in fermentation-based APIs with a strong presence in immunosuppressants and oncology segments. Analyst Outlook: Target price of ₹2,300, indicating a potential upside of approximately 8.1%.